Allakos
ALLK
ALLK was delisted on the 15th of May, 2025.
72 hedge funds and large institutions have $928M invested in Allakos in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 9 reducing their positions, and 12 closing their positions.
311% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 9
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
11% more funds holding
Funds holding: 65 → 72 (+7)
3% more capital invested
Capital invested by funds: $898M → $928M (+$29.4M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$59.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.5M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
+$32.3M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$28.5M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$24.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$30.2M |
| 2 |
Jennison Associates
New York
|
-$15.4M |
| 3 |
O
OrbiMed
New York
|
-$9.15M |
| 4 |
ACM
Atika Capital Management
New York
|
-$4.7M |
| 5 |
PIM
Partner Investment Management
San Francisco,
California
|
-$4.3M |
ALLK Hedge Fund Activity: Q1 2019 in Review
72 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Allakos (ALLK) for Q1 2019, worth a combined $928M — up 3.3% from $898M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ALLK positions and 12 closed out — a net gain of 7 holders — while 37 added to existing stakes and 9 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $59.8M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $30.2M sold.
- 72 institutional investors held Allakos (ALLK) as of Q1 2019, up from 65 in Q4 2018.
- Funds reported $928M of Allakos stock for Q1 2019, up 3.3% quarter-over-quarter.
- 19 funds opened new Allakos positions in Q1 2019 and 12 closed out, a net change of +7 holders.
- The largest Allakos buyer in Q1 2019 was Fidelity Investments, an estimated $59.8M added.
- The largest Allakos seller in Q1 2019 was PFM Health Sciences, an estimated $30.2M sold.
Based on aggregated 13F filings for Q1 2019.